Blue Cross Blue Shield of Minnesota Medical Policy

 
 

Medical Policy:
II-70-003
Topic:
Biofeedback
Section:
Medicine
Effective Date:
January 30, 2023
Issued Date:
October 30, 2023
Last Revision Date:
November 2022
Annual Review:
October 2023
 
 

This Policy version was replaced on October 28, 2024. To find the newest version, go to https://www.bluecrossmn.com/providers/medical-management, select 'See Medical and Behavioral Health Policies', then 'Blue Cross and Blue Shield of Minnesota Medical and Behavioral Health Policies'. This will bring up the Medical Policy search screen. Enter the policy number without the version number (last three digits). 

Biofeedback is a technique to teach patients self-regulation of physiologic processes not generally considered to be under voluntary control. Biofeedback devices may include electromyography (EMG), electrocardiography (ECG), measures of skin temperature and measures of the skin's electrical conductivity by the amount of sweat produced under stress.

A variety of biofeedback devices have been cleared for marketing by the U.S. Food and Drug Administration (FDA) through the 510(k) process. A biofeedback device is defined by the FDA as "an instrument that provides a visual or auditory signal corresponding to the status of one or more of a patient's physiological parameters (e.g., brain alpha wave activity, muscle activity, skin temperature, etc.) so that the patient can control voluntarily these physiological parameters."

NOTE:  Devices that provide information about neuronal activity as measured by electroencephalogram (EEG) or functional magnetic resonance imaging (fMRI) are addressed in policy X-29 Neurofeedback.

This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Policy Position Coverage is subject to the specific terms of the member's benefit plan.

I.    Biofeedback for Behavioral Health Conditions

  • Biofeedback in a supervised clinical setting may be considered MEDICALLY NECESSARY AND APPROPRIATE as one component of a comprehensive treatment plan for the following behavioral health conditions: 
    • Generalized anxiety; 
    • Panic disorders.
  • Biofeedback is considered EXPERIMENTAL/INVESTIGATIVE for treatment of all other behavioral health conditions, due to a lack of evidence demonstrating an impact on improved health outcomes.

II.   Biofeedback for Medical Conditions

  • Biofeedback in a supervised clinical setting may be considered MEDICALLY NECESSARY AND APPROPRIATE as a component of a comprehensive treatment plan for the following medical conditions:
    • Cancer-related pain 
    • Chronic pain 
    • Dyssynergia-type chronic constipation in adults 
    • Fecal incontinence in adults 
    • Intractable musculoskeletal spasm 
    • Migraine or chronic, recurrent tension-type headache 
    • Temporomandibular disorder (TMD). (Refer to policy II-07, Treatment for Temporomandibular Disorder, for information on additional treatments of TMD) 
    • Urinary incontinence in adults
  • Biofeedback is considered EXPERIMENTAL/INVESTIGATIVE for treatment of all other medical conditions including but not limited to the following due to a lack of evidence demonstrating an impact on improved health outcomes:
    • Asthma 
    • Bell’s palsy 
    • Chronic fatigue syndrome 
    • Cluster headache 
    • Fecal or urinary incontinence in pediatric patients 
    • Hypertension 
    • Movement disorders 
    • Multiple sclerosis 
    • Ordinary muscle tension 
    • Pain management during labor 
    • Prevention of preterm birth 
    • Raynaud’s disease or phenomenon 
    • Recovery of motor function after stroke 
    • Sleep bruxism 
    • Spinal cord injury 
    • Tinnitus

III.  Use of biofeedback in the home or an unsupervised setting for any indication is considered EXPERIMENTAL/INVESTIGATIVE due to a lack of clinical evidence demonstrating an impact on improved health outcomes.

 

90875 90876 90901 90912 90913








Links





Blue Cross and Blue Shield of Minnesota medical policies apply generally to all Blue Cross and Blue Plus plans and products. Benefit plans vary in coverage and some plans may not provide coverage for certain services addressed in the medical policies. When determining coverage, reference the member’s specific benefit plan, including exclusions and limitations.

Medicaid products may provide different coverage for certain services, which may be addressed in different policies. For Minnesota Health Care Program (MHCP) policies, please consult the MHCP Provider Manual website.

Medicare products may provide different coverage for certain services, which may be addressed in different policies. For Medicare National Coverage Determinations (NCD), Local Coverage Determinations (LCD), and/or Local Coverage Articles, please consult CMS, National Government Services, or CGS websites. 

Note that services with specific coverage criteria may be reviewed retrospectively to determine if criteria are being met. Retrospective denial of claims may result if criteria are not met.

Blue Cross and Blue Shield of Minnesota reserves the right to revise, update and/or add to its medical policies at any time without notice. Codes listed on this policy are included for informational purposes only and are subject to change without notice. Inclusion or exclusion of a code does not constitute or imply member coverage or provider reimbursement. 

These guidelines are the proprietary information of Blue Cross and Blue Shield of Minnesota. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.

Acknowledgements:

CPT® codes copyright American Medical Association® 2023. All rights reserved.

CDT codes copyright American Dental Association® 2023. All rights reserved.